Clinical research for appropriate total parenteral nutrition in patients with chronic kidney disease at stages 3, 4 and 5

Clinical research for appropriate total parenteral nutrition in patients with chronic kidney disease at stages 3, 4 and 5 - Appropriate total parenteral nutrition in patients with chronic kidney disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002223

Enrollment

Registered

2015-01-01

Start date

2009-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic kidney disease

Interventions

Total pareteral nutrition

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Chronic kidney disease at stages 3, 4, and 5 2) Indication for total pareteral nutrition

Exclusion criteria

Exclusion criteria: 1) Severe liver function 2) Severe coagulation disturbance 3) Contraindication for administration of ingredients of total pareteral nutrition

Design outcomes

Primary

Measure	Time frame
Concentration of ingredients in total parenteral nutrition	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026